Free press releases distribution network?

Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Cold Chain Service Providers to Benefit From the Strong growth of the Biopharmaceutical Market Finds IMARC Group - A new report from IMARC Group expects the strong growth of biopharmaceuticals and the launch of biosimilars to create huge opportunities for cold chain service providers
Cold Chain Service Providers to Benefit From the Strong growth of the Biopharmaceutical Market Finds IMARC Group

 

PRZOOM - /newswire/ - Noida, Uttar Pradesh, India, 2011/09/05 - A new report from IMARC Group expects the strong growth of biopharmaceuticals and the launch of biosimilars to create huge opportunities for cold chain service providers.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Driven by strong efficacies, target oriented attack and high margins; the market for biopharmaceuticals is expected to grow robustly in the coming years reaching values worth US$ 159 Billion by 2016. IMARC Group, one of the worlds’s leading research and advisory firms in its new report “Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)” expects the growth of the biopharmaceutical market to create huge demand for efficient cold chain logistic services. Findings from the report suggest that biopharmaceuticals are highly temperature sensitive and are recommended to be stored and transported at temperatures ranging from 2°- 8°C. Any failures in the cold chain transportation of these drugs can lead to a significant loss of their efficacy and can even make them harmful for the patient. Regulatory agencies have in fact stated that drugs that have been temperature abused are every bit as dangerous as those that are not authentic.

Findings from the report also suggest that the entry of biosimilars or generic versions of branded biopharmaceuticals will further increase the demand for cold chain logistic services. The reports expect biosimilars to be 20% - 60% cheaper than branded biopharmaceuticals. This is expected to significantly increase their patient pools and thereby expand the overall shipment volume of these drugs. The report also expects some of the important biosimilar manufactures to be based in Asian Countries e.g. Dr Reddy’s (India), Celltrion (Korea), etc. Since the manufacturing facilities of these companies will be based in Asia and their end user markets will be based in the US and Europe, the report expects a significant increase in the exports of biopharmaceuticals between these regions.

Key Aspects Analyzed in this Report:
Comprehensive Market Analysis of Temperature Sensitive Health Care Products:
Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial Materials

Focus of the Analysis in Each Class:
• Drivers and challenges
• Historical sales trends
• Logistic requirements
• Impact of temperature excursions
• Opportunities in cold chain services
• Market outlook (2011-2016)

Understanding the Operations of a Health Care Cold Chain Distribution Process
Focus of the Analysis:
• Understanding the various methods of cold chain distribution and their advantages/disadvantages
• Understanding the cold chain requirements of various temperature sensitive products and the impact of temperature excursion
• Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation
• Understanding the key steps required in the setting and organization of an efficient cold chain distribution process

Comprehensive Market Analysis of the Health Care Cold Chain Logistic Services Market
Focus of the analysis:
• Quantifying the global health care cold chain logistic services market
• Quantifying the market size by product
• Quantifying the market size by service
• Quantifying the market size by region

Information Sources:
Information has been sourced from both primary and secondary sources:
• Primary sources include industry surveys and face to face/telephone interviews with industry experts.
• Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.

Table of Contents:

1 Research Methodology & Market Definitions
2 Executive Summary
3 The Global Healthcare Cold Chain Logistics Market
3.1 Current Trends
3.1.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
3.1.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
3.1.3 Outsourcing Trends in Research & Manufacturing Have Increased Logistic Demands
3.1.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
3.1.5 Cost is Not Always the Most Important Driver in Supplier Decisions
4 The Global Healthcare Cold Chain Products Market
4.1 Current Market Trends & Forecast
4.2 Market Segments
4.2.1 Biopharmaceuticals
4.2.1.1 Current Market Trends & Forecast
4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
4.2.2 Vaccines
4.2.2.1 Current Market Trends & Forecast
4.2.2.2 Cold Chain Requirements for Vaccines
4.2.2.3 Cold Chain Opportunities for Vaccines
4.2.3 Clinical Trial Materials
4.2.3.1 Current Market Trends & Forecast
4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials
5 Healthcare Cold Chain Logistics: How Does It Operate?
5.1 Cold Chain Packaging & Transportation Methods
5.1.1 Dry Ice
5.1.2 Liquid Nitrogen
5.1.3 Gel Packs
5.2 Modeling the Cost of Cold Chain Packaging & Transportation
5.3 The Setting & Organization of Cold Chains
5.3.1 Initial Considerations
5.3.2 Choosing the Correct Model
5.3.3 Regulatory/Custom Clearance
5.3.4 Final Stages
5.3.5 Quality Assurance
6 The Healthcare Cold Chain Logistic Services Market
6.1 Current Trends & Forecast
6.2 Market Segmentation
6.2.1 Market by Product
6.2.1.1 Biopharmaceuticals & Vaccines
6.2.1.2 Clinical Trial Materials
6.2.2 Market by Service
6.2.2.1 Packaging & Instrumentation
6.2.2.2 Transportation
6.2.3 Market by Region
6.2.3.1 North America
6.2.3.2 Europe
6.2.3.3 Asia Pacific
6.2.3.4 Rest of the World
7 Challenges in the Healthcare Cold Chain Logistics Market
7.1 Cold Chain Infrastructure Remains Underdeveloped in Many Regions
7.2 Lack of Funding to Implement an Efficient Cold Chain Infrastructure
7.3 New Technologies Nullifying the Need of Cold Chains
8 Key Company Profiles
8.1 World Courier
8.2 DHL
8.3 Fedex
8.4 United Parcel Service
8.5 Kuehne and Nagel
8.6 Cavalier Logistics
8.7 DB Schenker
8.8 Life ConEx
8.9 American Airlines Cargo
8.10 Continental Air Cargo
8.11 Marken.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Cold Chain Service Providers to Benefit From the Strong growth of the Biopharmaceutical Market Finds IMARC Group

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Krishna Sharma - IMARCgroup.com 
+91 12 04155099 press[.]imarcgroup.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From IMARC Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today